Cargando…
Preclinical Efficacy of a Capsid Virus-like Particle-Based Vaccine Targeting IL-1β for Treatment of Allergic Contact Dermatitis
Hypersensitivity to a contact allergen is one of the most abundant forms of inflammatory skin disease. Today, more than 20% of the general population are sensitized to one or more contact allergens, making this disease an important healthcare issue, as re-exposure to the allergen can initiate the cl...
Autores principales: | Goksøyr, Louise, Funch, Anders B., Okholm, Anna K., Theander, Thor G., de Jongh, Willem Adriaan, Bonefeld, Charlotte M., Sander, Adam F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143278/ https://www.ncbi.nlm.nih.gov/pubmed/35632584 http://dx.doi.org/10.3390/vaccines10050828 |
Ejemplares similares
-
Dendritic Epidermal T Cells in Allergic Contact Dermatitis
por: Mraz, Veronika, et al.
Publicado: (2020) -
Head-to-Head Comparison of Modular Vaccines Developed Using Different Capsid Virus-Like Particle Backbones and Antigen Conjugation Systems
por: Fredsgaard, Laurits, et al.
Publicado: (2021) -
A cVLP-Based Vaccine Displaying Full-Length PCSK9 Elicits a Higher Reduction in Plasma PCSK9 Than Similar Peptide-Based cVLP Vaccines
por: Goksøyr, Louise, et al.
Publicado: (2022) -
Allergic contact dermatitis masquerading as atopic dermatitis
por: Semaan, Sarah, et al.
Publicado: (2020) -
Allergic Contact Dermatitis to Superglue
por: Sornakumar, L, et al.
Publicado: (2013)